382
Views
28
CrossRef citations to date
0
Altmetric
Review

Epidemiology and prevention of meningococcal disease: a critical appraisal of vaccine policies

&
Pages 1717-1730 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Lidia Serra, Markus Knuf, Federico Martinón-Torres, Kevin Yi & Jamie Findlow. (2021) Review of clinical studies comparing meningococcal serogroup C immune responses induced by MenACWY-TT and monovalent serogroup C vaccines. Human Vaccines & Immunotherapeutics 17:7, pages 2205-2215.
Read now
Marco Aurelio P. Safadi, Federico Martinón-Torres, Lidia Serra, Cynthia Burman & Jessica Presa. (2021) Translating meningococcal serogroup B vaccines for healthcare professionals. Expert Review of Vaccines 20:4, pages 401-414.
Read now
Robert Booy, Angela Gentile, Michael Nissen, Jane Whelan & Véronique Abitbol. (2019) Recent changes in the epidemiology of Neisseria meningitidis serogroup W across the world, current vaccination policy choices and possible future strategies. Human Vaccines & Immunotherapeutics 15:2, pages 470-480.
Read now
Lara Evellyn do Macedo, Viviane Matos Ferreira, Caroline Alves Feitosa, Amélia Maria Pithon Borges Nunes, Leila Carvalho Campos & Marco Aurélio Palazzi Sáfadi. (2018) Impact of meningococcal C conjugate vaccination programs with and without catch-up campaigns in adolescents: Lessons learned from Bahia, Brazil. Human Vaccines & Immunotherapeutics 14:5, pages 1131-1137.
Read now
Anne Abio, Keith R. Neal & Charles R. Beck. (2013) An epidemiological review of changes in meningococcal biology during the last 100 years. Pathogens and Global Health 107:7, pages 373-380.
Read now
Marco Aurélio P Sáfadi, Luz Elena Espinosa de los Monteros, Eduardo Luis López, Xavier Sàez-Llorens, Ana Paula Lemos, Sarbelio Moreno-Espinosa, Silvia González Ayala, Juan Pablo Torres, José Cassio de Moraes & Julio Alberto Vázquez. (2013) The current situation of meningococcal disease in Latin America and recommendations for a new case definition from the Global Meningococcal Initiative. Expert Review of Vaccines 12:8, pages 903-915.
Read now
Michael Bröker, Susanne Jacobsson, Markku Kuusi, David Pace, Maria J. Simões, Anna Skoczynska, Muhamed-Kheir Taha, Maija Toropainen & Georgina Tzanakaki. (2012) Meningococcal serogroup Y emergence in Europe. Human Vaccines & Immunotherapeutics 8:12, pages 1907-1911.
Read now
Kim S. Erlich & Blaise L. Congeni. (2012) Importance of circulating antibodies in protection against meningococcal disease. Human Vaccines & Immunotherapeutics 8:8, pages 1029-1035.
Read now

Articles from other publishers (20)

Sandra Guedes, Hélène Bricout, Edith Langevin, Sabine Tong & Isabelle Bertrand-Gerentes. (2022) Epidemiology of invasive meningococcal disease and sequelae in the United Kingdom during the period 2008 to 2017 – a secondary database analysis. BMC Public Health 22:1.
Crossref
Serge Mazamay, Didier Bompangue, Jean-François Guégan, Jean-Jacques Muyembe, Francis Raoul & Hélène Broutin. (2020) Understanding the spatio-temporal dynamics of meningitis epidemics outside the belt: the case of the Democratic Republic of Congo (DRC). BMC Infectious Diseases 20:1.
Crossref
Ricardo Becker Feijo & Juarez Cunha. (2020) Trajectory of serogroups causing Invasive Meningococcal Disease in Santa Catarina state, Brazil (2007–2019). The Brazilian Journal of Infectious Diseases 24:4, pages 349-351.
Crossref
Jéssica Vespa Presa, Maria Gabriela Abalos, Rodrigo Sini de Almeida & Alejandro Cane. (2019) Epidemiological burden of meningococcal disease in Latin America: A systematic literature review. International Journal of Infectious Diseases 85, pages 37-48.
Crossref
Al-Mamoon Badahdah, Ameneh Khatami, Mohamed Tashani, Harunor Rashid & Robert Booy. (2018) Evidence for Rise in Meningococcal Serogroup C Bactericidal Antibody Titers in the Absence of Booster Vaccination in Previously Vaccinated Children. Pediatric Infectious Disease Journal 37:3, pages e66-e71.
Crossref
Marco A. P. Sáfadi, María Teresa ValenzuelaAna Flavia CarvalhoLúcia Helena De OliveiraDavid M SalisburyJon Kim Andrus. (2017) Knowing the scope of meningococcal disease in Latin America. Revista Panamericana de Salud Pública 41, pages 1.
Crossref
Tatjana Baldovin, Roberta Lazzari, Silvia Cocchio, Patrizia Furlan, Chiara Bertoncello, Mario Saia, Francesca Russo & Vincenzo Baldo. (2017) Invasive meningococcal disease in the Veneto region of Italy: a capture-recapture analysis for assessing the effectiveness of an integrated surveillance system. BMJ Open 7:4, pages e012478.
Crossref
Andrew B Janowski & Jason G Newland. (2017) From the microbiome to the central nervous system, an update on the epidemiology and pathogenesis of bacterial meningitis in childhood. F1000Research 6, pages 86.
Crossref
Amélia Maria Pithon Borges Nunes, Guilherme Sousa Ribeiro, Ítalo Eustáquio Ferreira, Ana Rafaela Silva Simões Moura, Ridalva Dias Martins Felzemburgh, Ana Paula Silva de Lemos, Mitermayer Galvão Reis, José Cassio de Moraes & Leila Carvalho Campos. (2016) Meningococcal Carriage among Adolescents after Mass Meningococcal C Conjugate Vaccination Campaigns in Salvador, Brazil. PLOS ONE 11:11, pages e0166475.
Crossref
Christine M. Arcari. 2015. Vaccinology. Vaccinology 304 318 .
M. Sadarangani, D. W. Scheifele, S. A. Halperin, W. Vaudry, N. Le Saux, R. Tsang, J. A. Bettinger, N. Bridger, R. Morris, S. Halperin, K. Top, P. Dery, D. Moore, M. Lebel, N. Le Saux, D. Tran, L. Ford-Jones, J. Embree, B. Law, R. Tsang, B. Tan, W. Vaudry, T. Jadavji, O. G. Vanderkooi, D. Scheifele, L. Sauve & J. Bettinger. (2014) The Impact of the Meningococcal Serogroup C Conjugate Vaccine in Canada Between 2002 and 2012. Clinical Infectious Diseases 59:9, pages 1208-1215.
Crossref
Marco Aurelio Palazzi Sáfadi, Telma Regina Marques Pinto Carvalhanas, Ana Paula de Lemos, Maria Cecilia Outeiro Gorla, Maristela Salgado, Lucila O. Fukasawa, Maria Gisele Gonçalves, Fabio Higa, Maria Cristina Cunto Brandileone, Claudio Tavares Sacchi, Ana Freitas Ribeiro, Helena Keico Sato, Lucia Ferro Bricks & José Cassio de Moraes. (2014) Carriage Rate and Effects of Vaccination after Outbreaks of Serogroup C Meningococcal Disease, Brazil, 2010. Emerging Infectious Diseases 20:5, pages 806-811.
Crossref
A. Gil, D. Barranco, J. Batalla, J.M. Bayas, M. Campins, P. Gorrotxategi Gorrotxategi, J. Lluch, F. Martinón-Torres, M.J. Mellado, D. Moreno-Pérez, B. Uriel & J.A. Vázquez. (2014) Prevención de la enfermedad meningocócica por el serogrupo B mediante una vacuna de 4 componentes. Anales de Pediatría 80:4, pages 259.e1-259.e23.
Crossref
Ricardo Walter Rüttimann, Angela Gentile, Mercedes Macias Parra, Xavier Saez-Llorens, Marco Aurelio Palazzi Safadi & Maria Elena Santolaya. (2014) A Consensus Statement. Pediatric Infectious Disease Journal 33:3, pages 284-290.
Crossref
Thomas A. Russo, Janet M. Beanan, Ruth Olson, Ulrike MacDonald, Andrew D. Cox, Frank St. Michael, Evgeny V. Vinogradov, Brad Spellberg, Nicole R. Luke-Marshall & Anthony A. Campagnari. (2013) The K1 Capsular Polysaccharide from Acinetobacter baumannii Is a Potential Therapeutic Target via Passive Immunization. Infection and Immunity 81:3, pages 915-922.
Crossref
Raymond S.W. TsangBrigitte LefebvreFrances B. JamiesonRodica GilcaShelley L. DeeksJianwei Zhou. (2012) Identification and proposal of a potentially new clonal complex that is a common cause of MenB disease in central and eastern Canada. Canadian Journal of Microbiology 58:10, pages 1236-1240.
Crossref
D. Gendrel. (2012) Vaccins anti-méningococciques: des politiques vaccinales et des recommandations hétérogènes. Archives de Pédiatrie 19, pages S70-S76.
Crossref
James Wassil, E David G McIntosh, Davide Serruto, Lisa DeTora, Michael Bröker & Alan Kimura. (2012) The early clinical development of a multicomponent vaccine against meningococcal serogroup B. Clinical Investigation 2:5, pages 503-517.
Crossref
Johan Holst, Hanne Nøkleby & Julie A. Bettinger. (2012) Considerations for controlling invasive meningococcal disease in high income countries. Vaccine 30, pages B57-B62.
Crossref
Mariagrazia Pizza, Lisa DeTora & James Wassil. (2012) Advances in meningococcal vaccines. Clinical Practice 9:1, pages 101-117.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.